Bullet points of Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
- Sesame, a health-care marketplace, has launched a new clinical weight loss program that allows patients to access compounded versions of Novo Nordisk's obesity drug Wegovy for $249 per month.
- The program aims to help patients access obesity and diabetes treatments at a time when many branded drugs are in short supply, with Wegovy and Ozempic being part of a highly popular class of medications called GLP-1s.
- Sesame's program is more affordable than branded medications, with Wegovy and Ozempic costing around $1,000 per month before insurance, and most digital health companies do not include the cost of those medications.
- The company has partnered with a 503B compounding pharmacy to manufacture prefilled, single-use syringes of compounded semaglutide, which will be available to patients through the program.
- Patients will have to fill out an intake form, select a health-care provider, and complete lab work to participate in the program, which will also offer ongoing consultations and a content library.
- Sesame's president and co-founder, Michael Botta, said the company is committed to providing affordable and accessible healthcare options to patients struggling with obesity and related health issues.
- The program is available now, with the content library expected to be live in about two weeks, and patients who sign up in the interim will automatically gain access to it.
cnbc.com_2 / CNBC Business by Layer3.news
npub1a8…nw4tu
2024-08-21 10:05:46
in reply to nevent1q…mwuw
Author Public Key
npub1a824tlx9pzc807ddhyy0h9mhqkfjj9j360z2a9kcmxsy6gcjhfaqxnw4tuPublished at
2024-08-21 10:05:46Event JSON
{
"id": "8e42596661f12f2dae722d3a087089744ff9cead473c8977255878f0d750444e",
"pubkey": "e9d555fcc508b077f9adb908fb97770593291651d3c4ae96d8d9a04d2312ba7a",
"created_at": 1724234746,
"kind": 1,
"tags": [
[
"subject",
"Bullet points of Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program"
],
[
"p",
"e9d555fcc508b077f9adb908fb97770593291651d3c4ae96d8d9a04d2312ba7a"
],
[
"e",
"adfb5c622b60d16659636cb64ef9a6a5101816f4abec2d50136b51d950afb66b",
"wss://articles.layer3.news",
"root"
]
],
"content": "Bullet points of Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program\n- Sesame, a health-care marketplace, has launched a new clinical weight loss program that allows patients to access compounded versions of Novo Nordisk's obesity drug Wegovy for $249 per month.\n- The program aims to help patients access obesity and diabetes treatments at a time when many branded drugs are in short supply, with Wegovy and Ozempic being part of a highly popular class of medications called GLP-1s.\n- Sesame's program is more affordable than branded medications, with Wegovy and Ozempic costing around $1,000 per month before insurance, and most digital health companies do not include the cost of those medications.\n- The company has partnered with a 503B compounding pharmacy to manufacture prefilled, single-use syringes of compounded semaglutide, which will be available to patients through the program.\n- Patients will have to fill out an intake form, select a health-care provider, and complete lab work to participate in the program, which will also offer ongoing consultations and a content library.\n- Sesame's president and co-founder, Michael Botta, said the company is committed to providing affordable and accessible healthcare options to patients struggling with obesity and related health issues.\n- The program is available now, with the content library expected to be live in about two weeks, and patients who sign up in the interim will automatically gain access to it.\n",
"sig": "9009a422e38b3187f83872aa11f2c85cb63a3f61ce41bbf02e383181419191f9f2b7d51d119fdf3f578020434e2f042936a11511eb1ae6d6ece423bb66b266c5"
}